NCT06716437 Prehabilitation for Patients Undergoing Lung Cancer Surgery
| NCT ID | NCT06716437 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Melbourne |
| Condition | Lung Cancer (NSCLC) |
| Study Type | INTERVENTIONAL |
| Enrollment | 25 participants |
| Start Date | 2025-01-24 |
| Primary Completion | 2025-05-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 25 participants in total. It began in 2025-01-24 with a primary completion date of 2025-05-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Major surgery has been linked to running a marathon as in both represent large endeavours where the body will experience an increase in demands to supply the necessary energy. It has been alledged that, as one would train to prepare for a marathon, the same should be applied to surgery. The process of getting ready and/or fitter for surgery is frequently referred to as prehabilitation and it usually involves interventions on improving nutrition and diet, getting fit and improve emotional wellness. Prehabilitation can improve the recovery after surgery and reduce the time spent in hospital afterwards. This research seeks to determine whether a home based program of increased physical activity and breathing training can improve patients' physical and respiratory function in preparation for lung cancer surgery.
Eligibility Criteria
Inclusion Criteria: * Diagnosis of lung cancer and scheduled for lung resection surgery * Ability to understand and speak English to follow instructions and complete the intended assessments. * Age ≥ 18 years at the point of baseline screening * Provide written informed consent for the trial * Sufficient digital literacy to use a smartphone and mobile app * No contraindications for exercise Exclusion Criteria: * Other cancer diagnoses than lung cancer * Surgery scheduled in less than one week * Unstable psychiatric, cognitive or substance abuse disorders that would interfere with cooperation with the requirements of the trial
Contact & Investigator
Linda Denehy, PhD
PRINCIPAL INVESTIGATOR
University of Melbourne
Frequently Asked Questions
Who can join the NCT06716437 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Lung Cancer (NSCLC). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06716437 currently recruiting?
Yes, NCT06716437 is actively recruiting participants. Contact the research team at larae@unimelb.edu.au for enrollment information.
Where is the NCT06716437 trial being conducted?
This trial is being conducted at Parkville, Australia.
Who is sponsoring the NCT06716437 clinical trial?
NCT06716437 is sponsored by University of Melbourne. The principal investigator is Linda Denehy, PhD at University of Melbourne. The trial plans to enroll 25 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.